Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and nu 7441

erlotinib hydrochloride has been researched along with nu 7441 in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(nu 7441)		Trials
(nu 7441)		Recent Studies (post-2010) (nu 7441)
4,3537863,03393082

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)nu 7441 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.03
Bromodomain-containing protein 4Homo sapiens (human)1
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)0.03
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)0.03
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.13
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)1.7533
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.016
Serine/threonine-protein kinase mTORHomo sapiens (human)2.05
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.22
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.0242
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.03
Bromodomain testis-specific proteinHomo sapiens (human)3.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rajput, M; Singh, N; Singh, R; Singh, RP1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and nu 7441

ArticleYear
EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways.
    Life sciences, 2021, Dec-01, Volume: 286

    Topics: Chromones; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Humans; Male; Morpholines; Prostatic Neoplasms; Rad51 Recombinase

2021